Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2014, 23(5):353-358

Myocardial neovascularization in the Janus view

Maruąčáková L1, Poljak Z2, Bucová M1, Hulín I2
1 Imunologický ústav Lekárské fakulty Univerzita Komenského v Bratislave
2 Oddelenie klinickej patofyziológie Lekárská fakulta Univerzita Komenského v Bratislave, Slovenská republika

The cardiovascular system is developed in order to ensure an optimal supply of oxygen and nutrients to the cells. Neovascularization is the process of forming new blood vessels. Angiogenesis is a complex process of construction of vessels. Angiogenesis also takes place in the myocardium. This review illustrates the formation of new blood vessels in the myocardium at the cellular and molecular level. The authors emphasize the possible impact of treatment on this process.

Keywords: neovascularisation; myocardium; angiogenesis; hypoxia; HIF-1; atherosclerosis

Published: May 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maruąčáková L, Poljak Z, Bucová M, Hulín I. Myocardial neovascularization in the Janus view. Cardiology Letters. 2014;23(5):353-358.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jaipersad AS, et al. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63(1):1-11. Go to original source...
    2. Silvestre JS, Smajda DM, Levy BI. Postischemic revascularization: From cellular and molecular mechanisms to clinical applica­ tions. Physiological Reviews. 2013;93(4):1743-1802. Go to original source...
    3. Semenza GL. Hypoxia and cancer. Cancer Metastasis Reviews. 2007;26(2):223-224. Go to original source...
    4. Manalo DJ, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105(2):659-669. Go to original source...
    5. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. The Journal of Biological Chemistry 1993;268(29):21513-21518. Go to original source...
    6. Hu Y, Liu J, Huang H. Recent agents targeting HIF-1α for cancer therapy. Journal of Cellular Biochemistry. 2013;114(3):498509. Go to original source...
    7. Huang LE, et al. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America 1998;95(14):7987-7992. Go to original source...
    8. Tanimoto K, et al. Mechanism of regulation of the HIF-1α by the von Hippel-Lindau tumor suppressor protein. The EMBO Journal 2000;19(16):4298-4309. Go to original source...
    9. Ivan M, et al. HIF-α targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001;292(5516):464-468. Go to original source...
    10. Makino Y, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001;414:550-554. Go to original source...
    11. Poellinger L, Johnson RS. HIF-1 and hypoxic response: the plot thickens. Current Opinion in Genetics and Development 2004;14(1):81-85. Go to original source...
    12. Berra E, et al. HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation. FEBS Letters 2001;491(1-2):85-90. Go to original source...
    13. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Molecular Biology of the Cell. 2002;13(5):1792-1801. Go to original source...
    14. Semenza GL. Hypoxia and human disease and the Journal of Molecular Medicine. Journal of Molecular Medicine. 2007;85(12):1293-1294. Go to original source...
    15. Schoedel J, et al. High-resolution genome-wide mapping of HIFbinding sites by ChIP-seq. Blood. 2011;117(23):207-217. Go to original source...
    16. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends in Pharmacological Sciences. 2012;33(4):207-214. Go to original source...
    17. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Critical Reviews in Oncology/ Hematology. 2006;59(1):15-26. Go to original source...
    18. Goliasova T, Denko NC. 12 Hypoxia-Inducible factor 1 (HIF-1) Mediated Adaptive Responses in the Solid Tumor. In: Siemann DW. Tumor Microenvironment 2011;271-290. Go to original source...
    19. Naglova H, Bucova M. HMGB1 and its physiological and pathological roles. Bratisl Lek Listy 2012;113(3):163-171. Go to original source...
    20. De MR, et al. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol 2007;27:2377-2383. Go to original source...
    21. Oka T, et al. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res 2014;114(3):565-571. Go to original source...
    22. Riley PR, Smart N. Vascularizing the heart. Cardiovasc Res 2011;91:260-268. Go to original source...
    23. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the re­ naissance cell. Circ Res 2009;105:1164-1176. Go to original source...
    24. Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-448. Go to original source...
    25. Endoh H. Improved cardiac contractile functions in hypoxia-re­ oxygenation in rats treated with low concentration Co(2+). Am J Physiol Heart Circ Physiol. 2000;279(6):H2713-719. Go to original source...
    26. Feng W. Copper regulation of hypoxiainducible factor-1 activity. Mol Pharmacol. 2009;75:174-182. Go to original source...
    27. Kameda Y, et al. Effects of pitavastatin on pressure overloadinduced heart failure in mice. Circ J. 2012;76:1159-1168. Go to original source...
    28. Nishizawa T, et al. Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats. J Hypertens. 2010;28:1515-1526. Go to original source...
    29. Bjornheden T, et al. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol. 1999;19:870876. Go to original source...
    30. Kwon HM, Sangiorgi G, Ritman EL, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998;101:1551-1556. Go to original source...
    31. Moulton KS, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 2003;100:47364741. Go to original source...
    32. O'brien KD. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 1996;93:672-682. Go to original source...
    33. Pu KM, Sava P, Gonzalez AL. Microvascular targets for anti-fibrotic therapeutics. Yale J Biol Med. 2013;86(4):537-554.

    Return to the content